"CORE Training for Musculoskeletal Health: A Study on Adaptive Exercise Protocols"
Launched by IOANNIS TSARTSAPAKIS · Jun 10, 2025
Trial Information
Current as of June 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study is looking at how a special core exercise program affects muscle growth, balance, and overall function. The exercises combine different types of core training, including stability, strength, and high-intensity power moves, to see how they help the muscles around your middle body work better and improve your quality of life. Researchers will use tools like muscle activity sensors and ultrasound pictures, along with questionnaires, to understand the changes that happen over several weeks of training.
The study is open to healthy adults aged 25 to 35 who regularly exercise at least three times a week for an hour each time and have done so consistently for at least two years. This includes people who participate in activities like swimming, dance, hiking, or racket sports, but excludes those who already do focused core training like Pilates or CrossFit, or who have injuries or health issues that make intense exercise unsafe. Participants will follow the exercise program for eight weeks and attend assessments before and after to track progress. This study is not yet recruiting, but it aims to help us learn how adaptive core workouts can improve muscle health and everyday function in active adults.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 25-35 years
- • Physically active (≥3 sessions/week, ≥1 hour per session) for ≥2 years
- • No known musculoskeletal, cardiovascular, or neurological disorders
- • No engagement in structured core training programs
- • Available to attend all evaluation appointments
- • Able and willing to commit to the 8-week intervention program
- Exclusion Criteria:
- • Medical conditions that limit full-body or trunk movement
- • Cardiovascular/metabolic conditions contraindicating high-intensity exercise
- • Current participation in Pilates, CrossFit, or other core-specific protocols
- • Recent musculoskeletal injury affecting training eligibility
About Ioannis Tsartsapakis
Ioannis Tsartsapakis is a clinical trial sponsor engaged in advancing medical research through the coordination and oversight of clinical studies. With a commitment to scientific rigor and patient safety, Tsartsapakis contributes to the development of innovative therapies aimed at improving health outcomes. His involvement spans the planning, execution, and monitoring phases of clinical trials, ensuring adherence to regulatory standards and ethical guidelines.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Serres, Central Makedonia, Greece
Patients applied
Trial Officials
Ioannis Tsartsapakis, Ph.D.
Principal Investigator
Aristotle University of Thessaloniki, Greece
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported